BPA for sabril, xenazine, and northera. 1 year with four one year option periods.

Ended Awarded Last action

Contract number
36E79720A0006
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
  • VA797P12Q0002 Solicitation number
Last date to order 100% complete
IDV ceiling
$31,500,000.00
Award type
Single award
Who can order
Only the awarding agency
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Lundbeck LLC, a global pharmaceutical company, to provide specialized drugs and therapies to treat disorders of the central nervous system. The contract has a ceiling value of $31,500,000 and a period of performance from January 31, 2020 to January 30, 2025, with one-year option periods.

The specific drugs being procured under this BPA are Sabril (vigabatrin) for treatment-resistant seizures, Xenazine (tetrabenazine) for chorea associated with Huntington's disease, and Northera (droxidopa) for neurogenic orthostatic hypotension. These medications are used to treat neurological conditions prevalent among veterans seeking care through the VA healthcare system. The BPA allows VA Networks and VA Medical Centers to issue delivery orders to Lundbeck on a firm fixed price basis, without set-aside designations, to procure emergency supplies and bulk purchases of these pharmaceutical offerings.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00010 · 2025 public law pricing updates $0
Exercise an Option P00009 · Exercise option year 4 - BPA 36E79720A0006 $0
Supplemental Agreement for work within scope P00008 · 2024 public law pricing updates $0
Exercise an Option P00007 · Exercise option year 3 on BPA 36E79720A0006. $0
Supplemental Agreement for work within scope P00006 · 2023 public law pricing updates $0
Supplemental Agreement for work within scope P00005 · 2022 public law pricing updates $0
Exercise an Option P00004 · Exercise option year 2 $0
Supplemental Agreement for work within scope P00003 · 2021 public law pricing updates $0
Exercise an Option P00002 · Exercise option year 1 $0
Supplemental Agreement for work within scope P00001 · Northera product deletion. This product is now available for purchase through the pharmaceutical prime vendor - mckesson plasma & biologics. $0
Original award $0
Show all 11

Quick answers

Who was awarded contract 36E79720A0006?

36E79720A0006 was awarded to Lundbeck LLC by National Acquisition Center (Headquarters) on January 31, 2020.

How much is contract 36E79720A0006 worth?

36E79720A0006's own ceiling is $31,500,000.

Who can order from contract 36E79720A0006?

36E79720A0006 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.

Is contract 36E79720A0006 under another contract?

Yes. 36E79720A0006 is a blanket purchase agreement under 36F79719D0283, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36E79720A0006 competed?

The extent of competition for 36E79720A0006 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV